Skip to main content
. 2017 Jun 13;12(6):e0178801. doi: 10.1371/journal.pone.0178801

Table 5. Secondary outcome over 24 month period.

CsAM (N = 191) TacM (N = 167) P value
Death, n (%) 15 (7.9) 9 (5.4) 0.35
Graft loss, n (%) 14 (7.3) 12 (7.2) 0.96
BPAR, n (%) 38 (19.9) 18 (10.8) 0.02

Chi-square test was used for the efficacy related results over 24 months between the treatment groups. CsA: cyclosporine A with or without prednisone and MPS or MMF, Tac: tacrolimus with or without prednisone and MPS or MMF.